'Part of re­cov­ery is aware­ness': Pan­dem­ic casts harsh spot­light on in­dus­try-wide lack of di­ver­si­ty in clin­i­cal tri­als

5 years ago
R&D
In Focus

With at least one gas­tric can­cer ap­proval on the line, Mer­ck­'s Keytru­da scores nod for ear­ly pa­tients in chemo com­bo

5 years ago
Pharma
FDA+

No­var­tis’ $2B can­cer drug spurs ‘ground­break­ing’ PhI­II da­ta for prostate can­cer

5 years ago
R&D

Hop­ing to take drug R&D in­to the cloud, In­sight­ful Sci­ence snaps up da­ta man­age­ment out­fit Dot­mat­ics

5 years ago
Deals
R&D

Ex­clu­sive: Maze un­veils their $191M pipeline, tak­ing on Ver­tex and two long-sought con­di­tions

5 years ago
R&D

No­vo Nordisk slammed with an RTF as the FDA rais­es CMC is­sues

5 years ago
FDA+

Ash­er Bio­ther­a­peu­tics joins search for a bet­ter IL-2 sans the tox­i­c­i­ties

5 years ago
Financing

Mid­dle-of-the-night NIH state­ment rais­es con­cerns on As­traZeneca's US vac­cine tri­al read­out

5 years ago
Pharma
Coronavirus

Ex­clu­sive: Two M&A deals and $9B lat­er, Lon­nie Moul­der is ramp­ing up his lat­est biotech start­up. And this one comes ...

5 years ago
Startups

Re­gen­eron to seek EUA for low­er dose of Covid-19 mAb cock­tail as new tri­al shows ma­jor drop in risk of ...

5 years ago
Pharma
Coronavirus

Trans-Pa­cif­ic bis­pe­cif­ic play­er caps 'very chal­leng­ing' pan­dem­ic year with $120M to gain a foothold among the gi­ants

5 years ago
China

Roche cuts bait on late-stage study of Hunt­ing­ton's med tomin­ersen, an Io­n­is im­port with pri­or safe­ty flags

5 years ago
R&D

Elis­a­bet de los Pinos and her team fu­el up for a late-stage quest to de­liv­er a safe eye can­cer drug

5 years ago
Financing

Three biotechs set terms in a hunt for $475M-plus; Leap Ther­a­peu­tics earns a tri­al win across DKK1 high ex­press­ing ...

5 years ago
News Briefing

Take­da takes a swing at RNA small mol­e­cules with dis­cov­ery pact for mul­ti­ple po­ten­tial Evotec pro­grams

5 years ago
Deals
R&D

Covid-19 roundup: Dai­ichi's mR­NA shot en­ters the clin­ic; South Africa sells its As­traZeneca sup­ply to neigh­bors

5 years ago
Coronavirus

Pfiz­er has run 41 tri­als over 15 years for tanezum­ab. As ad­comm nears, the FDA re­mains unim­pressed — and more than ...

5 years ago
Pharma
FDA+

In­no­force gets $96M to build up Chi­na cam­pus, in­clud­ing a new Ther­mo Fish­er-part­nered mon­o­clon­al an­ti­body ...

5 years ago
Cell/Gene Tx
Manufacturing

Those NDA plans Odonate had for mid-'21? They're be­ing scrapped — along with the en­tire biotech — in a sud­den ...

5 years ago
R&D

PhRMA at­tacks New Mex­i­co’s ‘short on de­tail’ plan for Cana­di­an drug im­ports

5 years ago
Pharma
FDA+

Xy­lo­Cor finds new back­ing to push re­gen­er­a­tive heart dis­ease gene ther­a­py deep­er in­to the clin­ic

5 years ago
Financing
Cell/Gene Tx

Roche claims key win in the $12B ear­ly-stage check­point race

5 years ago
R&D
Pharma

As­traZeneca read­ies April EUA fil­ing with 79% vac­cine ef­fi­ca­cy, first glimpse of el­der­ly da­ta and 100% pro­tec­tion ...

5 years ago
R&D
Coronavirus

José Basel­ga, ac­claimed drug hunter, physi­cian and As­traZeneca's pi­o­neer­ing can­cer R&D chief, has died

5 years ago
People
First page Previous page 728729730731732733734 Next page Last page
A service from the Financial Times